IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 25 filers reported holding IMMUNIC INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32 | -25.6% | 22 | +29.4% | 0.00% | – |
| Q2 2023 | $43 | +4200.0% | 17 | +1600.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1 | -98.9% | 0.00% | – |
| Q3 2022 | $297,000 | -95.4% | 94 | -94.9% | 0.00% | – |
| Q2 2022 | $6,454,000 | -75.0% | 1,860 | -18.6% | 0.00% | – |
| Q1 2022 | $25,820,000 | -62.6% | 2,285 | -68.4% | 0.00% | – |
| Q4 2021 | $69,124,000 | +119.8% | 7,223 | +103.3% | 0.00% | – |
| Q3 2021 | $31,444,000 | +53.7% | 3,553 | +112.9% | 0.00% | – |
| Q2 2021 | $20,462,000 | -2.2% | 1,669 | +27.1% | 0.00% | – |
| Q1 2021 | $20,929,000 | +33.8% | 1,313 | +28.3% | 0.00% | – |
| Q4 2020 | $15,642,000 | -33.1% | 1,023 | -18.7% | 0.00% | – |
| Q3 2020 | $23,380,000 | +1395.8% | 1,259 | +876.0% | 0.00% | – |
| Q2 2020 | $1,563,000 | +5110.0% | 129 | +2480.0% | 0.00% | – |
| Q1 2020 | $30,000 | -37.5% | 5 | 0.0% | 0.00% | – |
| Q4 2019 | $48,000 | -97.5% | 5 | -97.4% | 0.00% | – |
| Q3 2019 | $1,920,000 | -12.8% | 192 | 0.0% | 0.00% | – |
| Q2 2019 | $2,202,000 | – | 192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
| Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
| INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
| Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
| RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
| Logos Global Management LP | 421,184 | $619,140 | 0.08% |
| Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
| BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
| Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
| COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |